MONTREAL, CANADA — Perceiv AI announces support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) in the form of advisory services and research and development funding totaling $180,000 CAD to advance our Alzheimer's disease solution.
SAN FRANCISCO, USA — Perceiv AI is proud to announce today that it has been selected to join the 2020 San Francisco Canadian Technology Accelerator for Health cohort. “We are delighted to join the CTA San Francisco accelerator’s 2020 cohort. We greatly look forward to working with leading life science industry mentors to help further develop our innovative, lifesaving technologies targeting neurodegenerative and cardiovascular diseases,” said CEO and co-founder Christian Dansereau.CTA Health SF
MONTREAL, CANADA — Perceiv AI presents a validation study of its prognostic enrichment tool for cognitive decline at the AAIC 2020 virtual conference - "Validation and Replication of a Prognostic Machine Learning Model for Enrichment of Cognitive Decliners in Clinical Trials". See the results here
MONTREAL, CANADA — Yoshua Bengio, Founder of Mila and computer science professor at University of Montreal, will support the ongoing research of Perceiv AI in precision medicine to improve and optimize drug development clinical trials.
MONTREAL, CANADA — Perceiv AI has started a project in partnership with vTv Therapeutics LLC (NASDAQ:VTVT) to evaluate Perceiv AI prognostic digital biomarkers technology. The goal is to improve clinical trials in Alzheimer’s disease by selecting individuals at a higher risk of cognitive decline.
MONTREAL, CANADA — Perceiv AI is proud to announce that they have been selected to be part of the Propulsion two-year program from the CENTECH accelerator. Perceiv AI will receive $25K in grant and move to their new offices in downtown Montreal at 400 Montfort street.
LOS ANGELES, USA — Perceiv AI Chief Executive Officer, Dr. Christian Dansereau, present results at AAIC 2019 - "PRE-SCREENING MACHINE LEARNING MODEL FOR β-AMYLOID POSITIVE ENRICHMENT". Results can be found in The Journal of the Alzheimer's Association, Vol. 15, Issue 7, P414–P415. https://doi.org/10.1016/j.jalz.2019.06.1011
BARCELONA, SPAIN — Dr. Christian Dansereau, Chief Executive Officer, speaks at CTAD 2018 - "IDENTIFYING RISK OF COGNITIVE DECLINE IN MILD COGNITIVE IMPAIRMENT FOR POPULATION ENRICHMENT OF CLINICAL TRIALS". Symposia. J Prev Alzheimers Dis 5, 1–45 (2018)